Science, Public Health Policy and the Law Story at a glance:
- The U.S. Food and Drug Administration (FDA) failed to prioritize over 70,000 adverse event reports related to puberty-blocking drugs, raising concerns about regulatory oversight of these medications.
- Side effects from puberty blockers range from headaches to serious conditions like brain swelling and vision loss.
- Puberty blockers disrupt normal development, causing long-term harm to physical development and psychological health in children.
- The FDA’s handling of puberty blockers demonstrates inconsistent regulatory standards and inadequate public warnings about significant risks.
- The safety of puberty blockers and other gender-affirming care has not been established, and parents should research risks before making decisions.
Imagine you’re handed a medicine for your child that promises to pause puberty, but no one’s fully checked if it’s safe. Puberty blockers are drugs that delay puberty, often used for children questioning their gender.
But recent reports show over 70,000 side effects — from headaches to brain swelling — haven’t gotten the attention they deserve from the people in charge.
Whether you’re a parent, a teen or just curious, this matters to you. Your health — or your loved one’s — could hinge on understanding the risks and who’s looking out for you.
Pausing puberty — A quick guide to these powerful drugs
Puberty-blocking drugs are given to children who have not yet entered puberty. These drugs delay the onset of sex characteristics associated with the gender you were at birth…
READ FULL ARTICLE HERE…
Home | Caravan to Midnight (zutalk.com)






Be First to Comment